首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis.
【24h】

A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis.

机译:一种使用一步聚合酶链反应/限制性片段长度多态性分析检测粪便样本中K-ras点突变以进行大肠癌筛查的简单方法。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We examined a technique for detecting point mutations of K-ras codon 12 in stool samples using one-step polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) analysis, in order to determine whether it could be used to screen for colorectal cancer. METHODS: DNA was extracted from 200-mg stool specimens of 5 healthy controls and 31 colorectal cancer patients. A 107-base-pair fragment of exon 1 of K-ras was amplified by PCR using mismatched primers. PCR products were digested with Bst NI and analyzed by gel electrophoresis followed by silver staining. Specificity of one-step PCR/RFLP was examined by using synthetic oligonucleotides. The detection limit of K-ras codon 12 mutations was determined by using SW480 and HT29 cells. RESULTS: The K-ras gene was successfully amplified from all healthy controls and colorectal cancer patients studied. Mutations of K-ras codon 12 were not detected in any of the healthy controls, but were identified in 13 (41.9%) of the 31 patients with colorectal cancer. Mutations were detectable in all six synthetic mutant DNAs, while none were detected among the wild type. The detection limit of this method was > or = 0.1%. CONCLUSIONS: PCR/RFLP analysis could be used in mass screening for colorectal cancer, because it is highly specific, has a low detection limit, and is simpler than conventional methods for detecting genetic abnormalities.
机译:背景:我们研究了一种使用一步聚合酶链反应/限制性片段长度多态性(PCR / RFLP)分析检测粪便样本中K-ras密码子12点突变的技术,以确定是否可用于筛选大肠癌。方法:从5名健康对照者和31名大肠癌患者的200毫克粪便标本中提取DNA。使用错配引物通过PCR扩增K-ras外显子1的107个碱基对片段。用Bst NI消化PCR产物,并通过凝胶电泳和银染进行分析。通过使用合成寡核苷酸检查一步PCR / RFLP的特异性。通过使用SW480和HT29细胞确定K-ras密码子12突变的检出限。结果:从所有健康对照和研究的大肠癌患者中成功扩增出K-ras基因。在任何健康对照中均未检测到K-ras密码子12突变,但在31例大肠癌患者中有13例(41.9%)被发现。在所有六个合成突变体DNA中均可检测到突变,而在野生型中均未检测到突变。此方法的检出限为>或= 0.1%。结论:PCR / RFLP分析可用于大肠癌的大规模筛查,因为它具有很高的特异性,检测限低,并且比常规的检测基因异常的方法更简单。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号